Does OMALIZUMAB Cause Dysarthria? 140 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 140 reports of Dysarthria have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.2% of all adverse event reports for OMALIZUMAB.
140
Reports of Dysarthria with OMALIZUMAB
0.2%
of all OMALIZUMAB reports
0
Deaths
100
Hospitalizations
How Dangerous Is Dysarthria From OMALIZUMAB?
Of the 140 reports, 100 (71.4%) required hospitalization, and 23 (16.4%) were considered life-threatening.
Is Dysarthria Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 140 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Dysarthria?
OLANZAPINE (900)
QUETIAPINE (669)
PREGABALIN (618)
AMLODIPINE (553)
GABAPENTIN (548)
METFORMIN (540)
METHOTREXATE (536)
DIAZEPAM (512)
ASPIRIN (495)
LORAZEPAM (483)
Which OMALIZUMAB Alternatives Have Lower Dysarthria Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS